Related Experiment Video
Updated: Feb 8, 2026

Adult Mouse Venous Hypertension Model: Common Carotid Artery to External Jugular Vein Anastomosis.
Published on: January 27, 2015
[Hypertension in older adults]
1Unidad de Hipertensión Arterial y Riesgo Vascular, Sección de Geriatría/Hospital de Día para el Paciente Crónico Complejo, Servicio de Medicina Interna, Hospital Clínic de Barcelona, IDIBAPS, Universidad de Barcelona, Barcelona, España.
Insights
Treating high blood pressure (hypertension) in older adults significantly reduces cardiovascular risks. Individualized treatment plans are crucial, considering patient health and life expectancy.
Area of Science:
- Geriatrics
- Cardiology
- Pharmacology
Background:
- Systolic hypertension is prevalent in over 68% of the elderly.
- Elderly hypertensive patients present unique challenges including altered pharmacokinetics, comorbidities, and polypharmacy.
Purpose of the Study:
- To review the benefits and considerations of antihypertensive treatment in the elderly population.
- To discuss blood pressure targets and treatment initiation in older adults.
Main Methods:
- Review of available evidence on antihypertensive treatment in individuals aged over 80 years.
- Discussion of factors influencing treatment decisions in elderly patients.
Main Results:
- Antihypertensive treatment in individuals over 80 years appears to reduce cardiovascular morbidity and mortality.
- Individualized treatment is recommended, assessing quality of life, life expectancy, and cardiovascular risk.
Conclusions:
- Antihypertensive therapy is beneficial for elderly individuals, reducing cardiovascular events.
- Treatment decisions and targets should be individualized based on patient-specific factors and guidelines.
Abstract:
The elevation of systolic blood pressure (BP) is a particularly significant event in the elderly population, where it is estimated that over 68% of the population is hypertensive. Treatment of hypertension in the elderly population is quite beneficial, but it would be necessary take into account some special characteristics of these patients, such as altered pharmacokinetics, comorbidity, or polypharmacy. The available evidence in individuals aged> 80 years seems to indicate that antihypertensive treatment results in a reduction of cardiovascular morbidity and mortality. In any case, it is advisable to individualize treatment and it should assess their quality of previous life, their life expectancy and cardiovascular risk situation. The BP from which to establish drug treatment or reduction targets to achieve BP are the points discussed in different international guidelines. © 2017 SEHLELHA. Published by Elsevier España, S.L.U. All rights reserved.
Related Concept Videos
Hypertension I: Introduction
Hypertension II: Pathophysiology
Hypertension V: Nursing Management
Hypertension and Regulation of Blood Pressure
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...
Adult Stem Cells

